Tiago Biachi de Castria, Medical Oncologist and Associate Member at Moffitt Cancer Center, shared a post on LinkedIn:
“Really excited to share that my investigator initiated trial using enfortumab vedotin in advanced colorectal cancer and hcc is now open.
Nectin-4 is highly expressed in both tumors and more options are urgently needed. Many thanks to Moffitt staff, Astellas and Dr Richard Kim for all support!”